GovWire

MDR number

MDR 230-03/23

Company name

Sandoz Limited

Product name

Co-amoxiclav 125/31.25mg/5ml powder for oral suspension, PL 04416/0514

SNOMED Code

6032711000001109

Product name

Co-amoxiclav 125/31.25mg/5ml powder for oral suspension (ALMUS LIVERY), PL 04416/0514

SNOMED Code

6032711000001109

Product name

Co-amoxiclav 250/62.5mg/5ml powder for oral suspension, PL 04416/0515

SNOMED Code

6034811000001107

Batch No	Expiry Date	Pack Size	First Distributed
KN7345	30/04/2023	1	24/06/2020
KN7348	30/04/2023	1	24/06/2020
KN7343	30/04/2023	1	24/06/2020
KN7344	30/04/2023	1	26/06/2020
KN7346	30/04/2023	1	29/06/2020
KN7349	30/04/2023	1	29/06/2020
KN7351	30/04/2023	1	09/07/2020
KN7355	30/04/2023	1	09/07/2020
KN7356	30/04/2023	1	10/07/2020
KN7358	30/04/2023	1	10/07/2020
KN7359	30/04/2023	1	04/08/2020
KU1888	31/07/2023	1	21/10/2020
KV9017	31/08/2023	1	12/11/2020
KV9018	31/08/2023	1	12/11/2020
KV9030	31/08/2023	1	19/11/2020
KV9015	31/08/2023	1	24/11/2020
KZ8872	31/10/2023	1	18/02/2021
KZ8870	31/10/2023	1	18/02/2021
KZ8869	31/10/2023	1	18/02/2021
LB0656	30/11/2023	1	22/02/2021
LA1951	31/10/2023	1	22/02/2021
KZ8863	31/10/2023	1	26/03/2021
LA1953	30/11/2023	1	08/04/2021
LA1954	30/11/2023	1	08/04/2021
KZ8864	31/10/2023	1	15/04/2021
KZ8866	31/10/2023	1	07/05/2021
LH0734	30/04/2024	1	24/06/2021
LH0736	30/04/2024	1	01/07/2021
LJ8596	31/12/2023	1	30/07/2021
LL7416	30/06/2024	1	09/09/2021
LM6701	31/08/2024	1	01/11/2021
LM6702	31/08/2024	1	02/11/2021
LM6705	31/08/2024	1	10/11/2021
LM6706	31/08/2024	1	10/11/2021
LR6835	31/10/2024	1	2/02/2022
LL9622	30/06/2024	1	22/02/2022
LP2509	31/08/2024	1	22/02/2022
MB  View the original news story Related Articles Scroll Back To Top 📄More Articles Class 4 Medicines Defect Information: Atnahs Pharma UK Limited, Clobazam Atnahs 5mg/5ml and 10mg/5ml Oral Suspension, EL(23)A/43Wednesday, 13 Dec Class 4 Medicines Defect Information: Rosemont Pharmaceuticals Ltd, Atorvastatin 4mg/ml Oral Suspension & Sildenafil 10mg/ml Oral Suspension , EL (22)A/39Wednesday, 14 Sep Product defect recall alert for Purevax® RCP FeLV lyophilisate and solvent for suspension for injection, Purevax® RCP lyophilisate solvent for suspension for injection, Eurican Herpes 205 Powder and Solvent for Emulsion for InjectionTuesday, 26 Mar Class 4 Medicines Defect Information: Sandoz Limited, Zinacef powder for solution for injection or infusion vials (all strengths, including stock in GSK livery), EL (23)A/38Monday, 23 Oct Class 2 Medicines Recall: Aventis Pharma Limited (t/a Sanofi), Stemetil 5mg/5ml Syrup, EL(22)A/41Thursday, 6 Oct Comments Scroll Back To Top ✎Write Comment We don't have any comments for this article yet. Why not join in and start a discussion. Write a Comment Scroll Back To Top Your name: Your email: Comments: Post my comment  Sponsored Advert   Ministerial Departmental News   PM's Office, 10 Downing Street   Cabinet Office   Department for Business, Innovation and Skills   Department for Communities and Local Government   Department for Culture, Media and Sport   Department for Education   Department for Environment, Food and Rural Affairs   Department for International Development   Department for Transport   Department for Work and Pensions   Department of Energy and Climate Change   Department of Health   Foreign and Commonwealth Office   HM Treasury   Home Office   Ministry of Defence   Ministry of Justice   Northern Ireland Office   Scotland Office   Wales Office   See all departments News Calendar Recent Comments  Sponsored Advert   Follow Us on Twitter Tweets by @gov_wire  Latest Government News How and when to submit research applications to ARSAC How to submit employer licence applications to ARSAC Promotional material: desider 2025 Current Crown Commercial Service suppliers: what you need to know Form: Application for extension of pre-charge bail Correspondence: CMA letter to Barclays about breaching Part 5 of the Retail Banking Order (notified in October 2024) SMFLH / MRL merger inquiry Transparency data: CMA board: register of interests Investigation into suspected anti-competitive conduct by Vifor Pharma in relation to intravenous iron treatments Aramark / Entier merger inquiry    Business Climate Crime Defence Economy Environment Housing Immigration NHS Overseas Schools Tax Transport Work ALL ❯ © 2025 Copyright CliqTo Media Ltd. Registered in England, company number 7575287. Privacy Policy | Terms & Conditions | Copyright Notice Contains public sector information licensed under the Open Government Licence v3.0. Share This Enjoyed this? Why not share it with others if you've found it useful by using one of the tools below: